shanghai - The world's largest producer of industrial enzymes will continue to increase investment in China, said Novozymes Executive Vice President Thomas Nagy.

"We are particularly dependent on energy markets in China. Since Novozymes' first plant was established in Tianjin in 1994, China has become one of our company's most important research and development (R&D), production and operation sites," he said.

Nagy also noted that the nation has played a crucial role in Novozymes' globalization strategy.